Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Sudabeh Shirazi-SouthallGeorge G Nomikos

Abstract

Some atypical antipsychotic drugs appear to improve cognitive function in schizophrenia and since acetylcholine (ACh) is of importance in cognition, we used in vivo microdialysis to examine the effects of antipsychotics administered acutely (SC or IP) at pharmacologically comparable doses on ACh outflow in the hippocampus of the rat. The atypical antipsychotics olanzapine and clozapine produced robust increases in ACh up to 1500% and 500%, respectively. The neuroleptics haloperidol, thioridazine, and chlorpromazine, as well as the atypical antipsychotics risperidone and ziprasidone produced modest increases in ACh by about 50-100%. Since most atypical antipsychotics affect a variety of monoaminergic receptors, we examined whether selective ligands for some of these receptors affect hippocampal ACh. Antagonists for the 5-HT(2A) (MDL 100,907), the 5-HT(2C) (SB 242,084), the 5-HT(6) (Ro 04-6790), the D(2) (raclopride) receptors, and the alpha(1)-adrenoceptors (prazosin) modestly increased ACh by about 50%. The 5-HT(1A) agonist R-(+)-8-OH-DPAT and the alpha(2)-adrenoceptor antagonist yohimbine significantly increased ACh by about 100% and 50%, respectively. Thus, olanzapine and clozapine increased ACh to a greater extent than other...Continue Reading

Citations

Aug 3, 2005·Psychopharmacology·Mark R Wade, George G Nomikos
Feb 4, 2012·European Journal of Drug Metabolism and Pharmacokinetics·Ramakrishna NirogiK Mukkanti
Jun 7, 2005·Pharmacology, Biochemistry, and Behavior·Amity GreenPradeep J Nathan
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Frank P BymasterDavid L Mckinzie
Feb 1, 2003·Biological Psychiatry·Herbert Y Meltzer, Tomiki Sumiyoshi
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Dec 17, 2009·Nature Neuroscience·Quoc-Thang NguyenDavid Kleinfeld
Apr 18, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mei HuangHerbert Y Meltzer
Jul 4, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Virginie Da Silva CostaFrançois Dauphin
Aug 7, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew G FoleyCiaran M Regan
Feb 3, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nii A AddyEdward D Levin
May 12, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jue HeXin-Min Li
May 19, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Zhu LiHerbert Y Meltzer
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cindy K J LiebenRudy Schreiber
Jul 14, 2005·Journal of Clinical Psychopharmacology·Ingrid AasenTonmoy Sharma
Sep 17, 2008·Journal of Clinical Psychopharmacology·Menahem I KrakowskiKaren A Nolan
May 26, 2012·Psychiatry and Clinical Neurosciences·Keiichiro MoriNaohisa Uchimura
Jul 26, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Kunrong ChengJean-Pierre Raufman
Nov 1, 2007·Journal of Dual Diagnosis·Sherry LeonardRobert Freedman
May 3, 2011·Expert Opinion on Drug Discovery·Altaf S DarveshCornelis J Van der Schyf
Jan 13, 2016·Reviews in the Neurosciences·Ahmed A MoustafaDorota Frydecka
Jul 6, 2015·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Diana RofailRay Fitzpatrick
Feb 15, 2011·Pharmacology, Biochemistry, and Behavior·Alvin V TerryScott J Webster
Feb 15, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Susanne H M GruberAleksander A Mathé
Dec 8, 2009·Medical Hypotheses·Marcelo O Ortells, Georgina E Barrantes
Sep 5, 2009·Brain Research·Kristin M WildeboerKaren E Stevens
Jul 19, 2015·Behavioural Brain Research·Anne QuiedevilleValentine Bouet
Feb 5, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Simret BerakiSven Ove Ogren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here